Cancer News and Research

Latest Cancer News and Research

Noninvasive optical imaging probes to determine amount and type of cell death in tumors

For quite some time, the "Holy Grail" in medical imaging has been the development of an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments. A new paper by researchers at the University of Notre Dame and the Washington University School of Medicine describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.

30 Jan 2010

Society publication strengthens oncology journals program

Beginning this year, Springer will add the Journal of Cancer Education (JCE) to its journals publishing program. Published on behalf of the American Association for Cancer Education and the European Association for Cancer Education, the quarterly journal features a varied editorial board made up of MDs and PhDs who support the dissemination of information on improving cancer education worldwide.

30 Jan 2010

LIVESTRONG and Nike form new strategy to raise global awareness on fight against cancer

Today LIVESTRONG® and NIKE, Inc. announced a new strategy for Nike’s LIVESTRONG product collection that will increase the partnership’s innovative efforts to raise awareness for the cancer fight globally and expand sales internationally.

30 Jan 2010

U.S. Marshals seize unapproved ozone generators from Applied Ozone Systems

At the request of the U.S. Food and Drug Administration, U.S. Marshals today seized 79 ozone generators, models AOS-1M and AOS-1MD, from Applied Ozone Systems of Auburn, Calif. The seized goods, which are medical devices, are valued at $75,900.

30 Jan 2010

LiveData OR-Dashboard completes 2010 IHE North American Connectathon

LiveData, a leading innovator in real-time data integration and display, today announced that the technology underlying LiveData OR-Dashboard, has successfully completed the 2010 IHE North American Connectathon, a proving ground for medical device integration.

30 Jan 2010

Health Secretary and education leader commend school for encouraging physical activities among students

During a visit today to Hanover Area Junior-Senior High School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to boost physical activity among middle school students.

30 Jan 2010

FDA approved 53 new oncology and hematology drugs between 2005 and 2007

Over a two and half year period, beginning in 2005 when the U.S. Food and Drug Administration's oncology drug product's office began reviewing marketing applications, a total of 60 new oncology and hematology drugs were reviewed, of which 53 were approved, according to a new article published online January 29 in the Journal of the National Cancer Institute.

30 Jan 2010

Salient Surgical Technologies, Exeter Hospital and Moffitt Cancer Center donate medical supplies to Haiti

Salient Surgical Technologies of Portsmouth, New Hampshire, has partnered with Exeter Hospital in Exeter, New Hampshire and Moffitt Cancer Center in Tampa, Florida, to donate equipment and supplies for a mission to aid victims of the January 12 earthquake in Haiti.

30 Jan 2010

AAPM reassures safety of radiation therapy

The American Association of Physicists in Medicine (AAPM) has issued a statement today in the wake of several recent articles in the New York Times yesterday and earlier in the week that discuss a number of rare but tragic events in the last decade involving people undergoing radiation therapy.

30 Jan 2010

Medical equipment could be a key weapon in stopping nuclear waste seeping into environment

Medical equipment used for diagnosis of patients with heart disease and cancer could be a key weapon in stopping nuclear waste seeping into the environment, according to new research.

From The University of Manchester 30 Jan 2010

Cardiologist provides heart-healthy tips for women

Heart disease is the single leading cause of death for American women. Nearly twice as many women in the United States die of heart disease, stroke and other cardiovascular diseases than from all forms of cancer, including breast cancer.

30 Jan 2010

Scientists currently working on 861 new cancer medicines

The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines.

30 Jan 2010

sigma-tau Group acquires Enzon’s specialty pharmaceutical business

Enzon Pharmaceuticals, Inc. ("Enzon") announced today that it has closed the sale of its specialty pharmaceutical business to the sigma-tau Group ("sigma-tau"). Enzon is a biopharmaceutical company dedicated to the discovery and development of important medicines for patients with cancer and other life-threatening conditions. Enzon's business now consists of its royalties, Peg SN38, LNA and PEG technology platforms.

30 Jan 2010

Breast cancer patient battles insurer; Recession burdens charity clinics

News outlets report on a patient's struggle to get coverage for cancer treatment and over-burdened charity clinics.

30 Jan 2010

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

30 Jan 2010

Surgeon General's report lays out recommendations to address childhood obesity

"As many as one in three children are overweight or obese, according to a new report" released yesterday by U.S. Surgeon General Regina Benjamin.

30 Jan 2010

Docking algorithm EADock allows successful design of new inhibitors for anti-cancer target

Many human tumors express indoleamine 2,3-dioxygenase (IDO), an enzyme which mediates an immune-escape in several cancer types. Researchers in the Molecular Modeling group at the SIB Swiss Institute of Bioinformatics and Dr. Beno-t J. Van den Eynde's group at the Ludwig Institute for Cancer Research Ltd (LICR) Brussels Branch developed an approach for creating new IDO inhibitors by computer-assisted structure-based drug design. The study was presented in the January 2010 online issue of the Journal of Medicinal Chemistry.

30 Jan 2010

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable more comprehensive genetic analysis of clinical and research samples, announced today that it has reached agreement with ZyGEM to non-exclusively market Rubicon's PicoPlex™ single-cell amplification kits in Australia and New Zealand.

30 Jan 2010

$Perifosine holds promise as a single agent for relapsed/refractory Waldenstrom's Macroglobulinemia$

Perifosine holds promise as a single agent for relapsed/refractory Waldenstrom's Macroglobulinemia

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.

30 Jan 2010

Salient Pharmaceuticals receives TETF commercialization award for CASAD therapy commercialization

Houston Technology Center (HTC), announced today that client company Salient Pharmaceuticals received a $2 million commercialization award from the Texas Emerging Technology Fund (TETF) for the commercialization of their CASAD therapy, an all natural product used to prevent and treat some cancer therapy-induced side effects.

29 Jan 2010

Cancer News and Research

Latest Cancer News and Research

Noninvasive optical imaging probes to determine amount and type of cell death in tumors

Society publication strengthens oncology journals program

LIVESTRONG and Nike form new strategy to raise global awareness on fight against cancer

U.S. Marshals seize unapproved ozone generators from Applied Ozone Systems

LiveData OR-Dashboard completes 2010 IHE North American Connectathon

Health Secretary and education leader commend school for encouraging physical activities among students

FDA approved 53 new oncology and hematology drugs between 2005 and 2007

Salient Surgical Technologies, Exeter Hospital and Moffitt Cancer Center donate medical supplies to Haiti

AAPM reassures safety of radiation therapy

Medical equipment could be a key weapon in stopping nuclear waste seeping into environment

Cardiologist provides heart-healthy tips for women

Scientists currently working on 861 new cancer medicines

sigma-tau Group acquires Enzon’s specialty pharmaceutical business

Breast cancer patient battles insurer; Recession burdens charity clinics

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

Surgeon General's report lays out recommendations to address childhood obesity

Docking algorithm EADock allows successful design of new inhibitors for anti-cancer target

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Perifosine holds promise as a single agent for relapsed/refractory Waldenstrom's Macroglobulinemia

Salient Pharmaceuticals receives TETF commercialization award for CASAD therapy commercialization

Industry Focus eBook: Oncology eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook: Oncology eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in